💊 GSK trims its cell therapy pipeline; The Pan-Gulf CDC is launched; CEPI ties up with SK bio

#202 | Watch out for the fun guy

Hello, and welcome back to The Kable. The US FDA is continuing with its spree of warning letters, this time for contract manufacturer Nephron over contamination issues at its manufacturing facility in South Carolina, US.

Elsewhere, GSK is culling its cell therapy work, terminating deals with Lyell Immunopharma and Adaptimmune. However, GSK hasn't (yet) ended its cell therapy deal signed in 2020 with Immatics.

Google's, sorry Alphabet's, Calico Labs has signed a new research collaboration in its quest to cure death. Calico is partnering with Terray Therapeutics to discover and develop small molecule therapeutics for age-related diseases.

If you're into medtech/digihealth and looking to manage dementia, the new Longitude Prize on Dementia has been launched, with a £1 million grand prize for a personalised, technology-based tool for people living with dementia. Applications are invited till January next year. The winning solution selected will be a digital device or service designed for use by people living with dementia as the primary users.

Traditional medicine continues to break new ground around the world. In the latest update, Bahrain is setting up a full-fledged Ayurvedic hospital.